For women of childbearing potential the majority of drugs used for lipid lowering therapy are unsafe to use in pregnancy. As a result, women with FH should receive pre-pregnancy counseling and instructions to stop statins, ezetimibe, and niacin at least 4 weeks before discontinuing contraception and should not use these medications during pregnancy. They should also consult their healthcare practitioner regarding continuation of any lipid-lowering medications, and this includes herbal supplements such as red yeast rice as well as fish oil products.
J Clin Lipidol. 2011; 5(6).